DavidTinChuMD

PubMed

• 3 citations
  Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Essential Thrombocythemia Enrolled in the MOST Study.
  Abdulraheem Yacoub, Roger M. Lyons, Srdan Verstovsek, Ryan Shao, David Tin Chu, Apurv Agrawal, Smitha Sivaraman, Philomena Colucci, Dilan Paranagama, John Mascarenhas> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Mar 1
• 1 citations
  The Risk of QTc Prolongation in Non-Diabetic and Diabetic Patients Taking Tyrosine Kinase Inhibitors (TKIs)- A Patient Safety Project at a Private Oncology Practice.
  Zhongju Lu, Ying Luu, Jack Ip, Imran Husain, Michael Lu, Chang-Kyung Kim, Peng Yang, David Chu, Richard Z. Lin, Ira L. Cohen, Alan Kaell> ;Journal of Community Hospital Internal Medicine Perspectives. 2021 Jan 1
• 3 citations
  Eosinophilic pneumonia associated with bleomycin in a patient with mediastinal seminoma: a case report
  Sanjaykumar Hapani, David Chu, Shenhong Wu> ;Journal of Medical Case Reports. 2010 Apr 29
• 129 citations
  Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis
  Sanjaykumar Hapani, Amna Sher, David Chu, Shenhong Wu> ;Oncology. 2010 Jan 1
• 301 citations
  Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis
  Sanjaykumar Hapani, David Chu, Shenhong Wu> ;The Lancet. Oncology. 2009 Jun 1
• 72 citations
  Risk of hand-foot skin reaction with the multitargeted kinase inhibitor sunitinib in patients with renal cell and non-renal cell carcinoma: a meta-analysis.
  David Chu, Mario E. Lacouture, Elizabeth Weiner, Shenhong Wu> ;Clinical Genitourinary Cancer. 2009 Jan 1
• Risk of Venous Thromboembolism with the Angiogenesis Inhibitor Bevacizumab in Cancer Patients: A Meta-Analysis
  David Chu, Roger Keresztes, Xiaolei Zhu, Shenhong Wu> ;JAMA. 2008 Nov 20
• 17 citations
  Novel therapies in breast cancer: what is new from ASCO 2008
  David Chu, Janice Lu> ;Journal of Hematology & Oncology. 2008 Oct 1
• 1 citations
  Novel therapies in genitourinary cancer: an update.
  David Chu, Shenhong Wu> ;Journal of Hematology & Oncology. 2008 Aug 11
• Risk of thromboembolism associated with an angiogenesis inhibitor bevacizumab in cancer patients.
  Chu DT, Nalluri SR, Wu S> ;J. Clin. Oncol.. 2008-05-20
• 6 citations
  Severe, refractory, non-malignant type I cryoglobulinemia treated with alemtuzumab.
  David Chu, Michelle Stevens, Douglas Edward Gladstone> ;Rheumatology International. 2007 Apr 19
• Outcomes of stroke patients in Medicare fee for service and managed care.
  Retchin SM, Brown RS, Yeh SC, Chu D, Moreno L> ;JAMA. 1997-07-09
• 138 citations
  Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis.
  David Chu, Mario E. Lacouture, Triantafillos Fillos, Shenhong Wu> ;Acta Oncologica. 2008 Jan 1
• Join now to see all